HER Technologies, Inc. is a privately held biotechnology company developing a critical suite of consumer technologies that safely and effectively restores skin to a healthier more youthful state. We anticipate that our initial innovations will significantly impact a stagnant aesthetic industry.
HER Innovations
HER Technologies, Inc. has developed three proprietary technology applications to address the poor performance of today’s anti-aging products. Our patented technology represents a major advancement in skin care and is the first designed to deliver electricity at a scale that safely simulates the body’s own bioelectricity levels. We call it HERTruth.™
We designed HERTruth™ to give consumers a highly effective over-the-counter (OTC) option to reverse cellular aging. Results are obvious and gratifying. It is affordable, painless, effective and for everyone desiring a younger appearance and healthier, more vibrant skin.
Investor Information
and Inquiries
HERTruth™ technologies train the cells by reminding them of their more youthful state. Diligent repetition over 12 weeks produces outstanding results. After the initial training, the time required to maintain excellent results is considerably less. Continued use produces further results.
HERTruth™ products enable ease-of-use at home and provide cost advantages that set it ahead of all existing competition in the consumer marketplace. The impact of our technologies is visibly obvious and clinically validated.
Our core technology for healing and restoring skin is Truth.™ All other HERTruth™ applications can be used in conjunction with Truth.™ With three different applications of our technology, consumers have the ability to choose the application that best suits their daily needs.
Sarah Stack, Founder and CEO
One of the founding pioneers of the “Disease Management” field of healthcare, Sarah Stack is now focusing her abilities, her experience and her history of success to enable consumers to achieve health and delay aging. Technology has transformed virtually every industry and Sarah has created HER Technologies, Inc. to transform how consumers secure their health with technology at home. Historically, Sarah created the vision for a disease management company in the respiratory field. She co-founded AirLogix, Inc., which gave respiratory therapists the opportunity to work with patients outside the hospital setting. Airlogix had revenues of approximately $10 million by the Company’s second full year of operations without any sales support staff. Sarah developed the strategy to consolidate the boutique industry of disease management companies. She sold her shares in AirLogix and subsequently took the position of Vice President of Strategic Development for Healthways, Inc., Nashville, TN to execute her consolidation strategy. She developed and executed a new strategic direction for the company and within 14 months of her hire Healthways (HWAY) stock escalated from $4 to $42. Sarah is a market-maker and game-changer. Her common sense innovations bring results that create and transform markets.
Lawrence A. Stanley, CFO
Mr. Stanley has over 45 years of financial and business management experience. He has been the Controller of a large division of a Fortune 50 company and President of a manufacturing subsidiary of a Fortune 1000 company. In the last 25 years Mr. Stanley has started and/or been involved in over 25 businesses. He currently sits on the Boards of Directors of several mid-sized privately held companies with diverse technologies. Mr. Stanley is also involved in land development, production of real estate radio programming and residential real estate sales.
Kris Foss, Chief Regulatory Officer
Kris is an accomplished strategic partner for innovative global medical device technology companies. Known for creative pre-market and post-market regulatory, clinical and quality planning capabilities, Kris develops global regulatory pathways that work. Her unique approach deploys senior staff members as acting regulatory representatives for client companies. Capabilities span pre-clinical, clinical, quality system and submission expertise.